The Association of Interleukin‐36 Staining Intensity and Response to Biologic Therapy in Patients With Psoriasis: A Retrospective Immunohistochemical and Chart Review Pilot Study
Journal of Cutaneous Pathology · 2025
DOI: 10.1111/cup.14729 ↗At a glance
Journal article in Journal of Cutaneous Pathology, 2025. Written by William R Zhang and 2 co-authors. Institution: Department of Dermatology, University of California, San Francisco, California, USA. Major MEDLINE topics: Psoriasis, Interleukin-1. 25 references. Funded by: UCSF Clinical and Translational Science Training Resident Research Funding Program.
Abstract (original language)
Background
There are limited surrogate biomarkers to identify the active inflammatory pathway in psoriasis to direct treatment with targeted biologic therapies. We investigated the association of interleukin (IL)‐36 epidermal expression, a diagnostic marker of psoriasis, with response to biologic therapy in patients with psoriasis.
Methods
Retrospective immunohistochemical and chart review pilot study.
Results
Patients with psoriasis with low (scores 0–2) vs. high (scores 3–4) IL‐36 expression did not have significantly different response rates to tumor necrosis factor α (TNFα), IL‐17, and IL‐12/23 or IL‐23 inhibitors; and similarly, mean IL‐36 expression scores did not significantly differ among responders vs. non‐responders to each treatment mechanism. However, in patients with psoriasis treated with IL‐12/23 or IL‐23 inhibitors, there was a marked absolute difference in response rates in those with high vs. low IL‐36 (84% vs. 50%, p = 0.12) and in mean IL‐36 scores in responders vs. non‐responders (3.35 vs. 2.57, p = 0.19).
Conclusions
Patients with psoriasis with high IL‐36 expression were more likely to respond to IL‐12/23 and IL‐23 inhibition than those with low IL‐36, though these findings were not statistically significant. Additional studies with larger sample sizes are needed to validate and expand upon these findings.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Dermatology, University of California, San Francisco, California, USA.
- Department of Pathology, University of California, San Francisco, California, USA.
ORCID profiles: William R Zhang, Jeffrey P North
Funding
- UCSF Clinical and Translational Science Training Resident Research Funding Program
Cite
APA
Zhang, W. R., Bhutani, T., & North, J. P. (2025). The Association of Interleukin‐36 Staining Intensity and Response to Biologic Therapy in Patients With Psoriasis: A Retrospective Immunohistochemical and Chart Review Pilot Study. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.14729
Vancouver
Zhang WR, Bhutani T, North JP. The Association of Interleukin‐36 Staining Intensity and Response to Biologic Therapy in Patients With Psoriasis: A Retrospective Immunohistochemical and Chart Review Pilot Study. Journal of Cutaneous Pathology. 2025. doi:10.1111/cup.14729
BibTeX
@article{Zhang2025,
author = {Zhang, William R and Bhutani, Tina and North, Jeffrey P},
title = {The Association of Interleukin‐36 Staining Intensity and Response to Biologic Therapy in Patients With Psoriasis: A Retrospective Immunohistochemical and Chart Review Pilot Study},
journal = {Journal of Cutaneous Pathology},
year = {2025},
doi = {10.1111/cup.14729}
}
EUVIMED